APA (7th ed.) Citation

Y, L., X, C., Y, L., T, Z., & S, L. (2018). Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer. Dove Medical Press.

Chicago Style (17th ed.) Citation

Y, Li, Cui X, Li Y, Zhang T, and Li S. Upregulated Expression of MiR-421 Is Associated with Poor Prognosis in Non-small-cell Lung Cancer. Dove Medical Press, 2018.

MLA (8th ed.) Citation

Y, Li, et al. Upregulated Expression of MiR-421 Is Associated with Poor Prognosis in Non-small-cell Lung Cancer. Dove Medical Press, 2018.